Track AI Answers

What does AI know about a brand?

TRACK BRANDS ON AI

Monitor your brand, company, or product's online reputation in AI responses

What does AI know about Kiniksa Pharmaceuticals Ltd.?

What does OpenAI free version (gpt-3.5-turbo) know about Kiniksa Pharmaceuticals Ltd.?

Last request 13.11.2023

(There is a high chance that below response is an AI hallucination)

Well Known No
Description Kiniksa Pharmaceuticals Ltd. is a biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutic medicines for patients with significant unmet medical needs.
Most Notable Achievements Kiniksa Pharmaceuticals Ltd. has a strong pipeline of potential treatments for a variety of diseases.
The Most Negative Fact Kiniksa Pharmaceuticals Ltd. is a relatively new company and has yet to bring any products to market.
Competition None
Share with friends

Register your email below to unlock features!

What does OpenAI paid version (gpt-4) know about Kiniksa Pharmaceuticals Ltd.?

Last request 27.12.2023
Well Known No
Description Kiniksa Pharmaceuticals Ltd. is a biopharmaceutical company that focuses on discovering, developing, and commercializing therapies for patients suffering from debilitating diseases with significant unmet medical need.
Most Notable Achievements Kiniksa Pharmaceuticals Ltd. has a strong pipeline of potential therapies for various diseases, including autoinflammatory and autoimmune diseases.
The Most Negative Fact Kiniksa Pharmaceuticals Ltd. has a limited track record of successful drug development and commercialization.
Competition None
Share with friends

What does Google AI (PaLM) know about Kiniksa Pharmaceuticals Ltd.?

Last request 27.12.2023
Well Known no
Description Kiniksa Pharmaceuticals Ltd. is a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapeutics in the areas of immunology and inflammation.
Most Notable Achievements Kiniksa Pharmaceuticals Ltd. has a strong pipeline of clinical-stage assets, including KPL-430, a first-in-class, oral, small molecule inhibitor of the IL-17A receptor, which is currently in Phase 2 clinical development for the treatment of atopic dermatitis and psoriasis.
The Most Negative Fact Kiniksa Pharmaceuticals Ltd. is a small, privately held company with limited financial resources.
Competition None

What does Microsoft Bing AI know about Kiniksa Pharmaceuticals Ltd.?

Well Known No
Description p attiu m aahimqciarLicldm,teeiggsmeaseigdpiieoa m mtctvuainkuoe s dirfnhoticeci etdnencnag eioie ans.rii, nu sdcdcainPun mmtrsceaKzoeis lpcnfndwa crcn el nhhluaigdtlb ipy p aacoseofoties.irarnvi c
Most Notable Achievements Kis fri pst chie inlovl y etgdseamoilt aati te.fadafen sarmtasp.okt ctp o nLPeanue nsatahresreri aios
The Most Negative Fact tyltha kptspwo a.PyrrnLt kc mncoiiirla btacl ti enit u ra saeau mrc.iosaohnv y dddgsaKenesa tnyeeam
Competition noNe

Register your email below to unlock features!

By signing up or logging in you agree to our Terms and Privacy Policy.